Alex Spira

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Alex Spira

May 30, 2025, 14:11 | Insight

HER3-Targeted Antibody-Drug Conjugate Shows Promise for Treatment-Resistant Solid Tumors

Preliminary results show that DB-1310 is both well-tolerated and effective in patients with heavily pretreated…

Jan 12, 2025, 15:28 | Insight

Mike Pishvaian: ‘Top Abstract Titles’ that I will be looking out for looking at ASCO GI

Mike Pishvaian, GI Oncologist at The Johns Hopkins University School of Medicine, shared on X:…

Sep 7, 2024, 16:05 | Blog

Antonio Passaro: Discussing the latest evidences on NSCLC harbouring EGFR mutations at ESMO24

Antonio Passaro shared a post on LinkedIn: "Join us at ESMO24 on Sunday, Sep 15, for…

Oct 2, 2023, 18:31 | Opinion

Vivek Subbiah: What a fantastic meeting packed with everything that’s needed for an early-phase drug development program.

Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on LinkedIn:…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023